BTXSMALL

BlackRock Technology and Private Equity Term Trust

HealthcareBiotechnology
$8.85
$0.00(+1.14%)
52W$6.13
$9.44
Updated Jun 30, 02:00 AM
RSI48
RS Rating80/99
Beta1.52
Volatility27%
F-Score3/9
Mkt Cap$1.0B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

BlackRock Technology and Private Equity Term Trust is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 80), indicating clear outperformance against the broad market. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.

Relative Strength
80
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.52
vs S&P 500
HIGH BETA
52W Position
82%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$8.57
50 SMA > 100 SMA$7.61
100 SMA > 150 SMA$7.31
150 SMA > 200 SMA$7.18

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$9.03-2.03%BELOW
50 SMA$8.57+3.27%ABOVE
100 SMA$7.61+16.33%ABOVE
150 SMA$7.31+21.14%ABOVE
200 SMA$7.18+23.23%ABOVE

Price Performance

1D+1.1%
1W-6.1%
1M-3.6%
3M+40.7%
6M+33.5%
YTD+32.3%
1Y+20.6%
3Y+4.5%
52-Week Trading Range82% from low
$8.85
52W Low$6.13
52W High$9.44

Technical Indicators

RSI (14)NEUTRAL
47.8
305070
Setup ScoreCOOL
5/10
Base depth: 32.7%

Risk Profile

Beta
1.52
52W Vol
27%
ATR
$0.32
Max DD (1Y)
-17%

Volume Analysis

Today
543.4K
50D Avg
704.4K
Vol Ratio
0.77x
Liquidity
MODERATE
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR

10 Years:-7.84%
5 Years:-15.37%
3 Years:+4.48%
1 Year:+20.57%

Return on Equity

10Y Avg:-14.7%
5Y Avg:-14.7%
3Y Avg:-14.3%
Last Year:1.9%

Key Metrics

Market Cap$1.0B
Gross Margin1.0%
Net Margin87.7%
Piotroski F-Score3/9

Frequently Asked Questions

Is BTX in an uptrend right now?

BTX has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, BTX is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is BTX overbought or oversold?

BTX's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.

Is BTX outperforming the market?

BTX has a Relative Strength (RS) Rating of 80 out of 99. Yes, BTX is a market leader, outperforming 80% of all stocks over the past 12 months.

Where is BTX in its 52-week range?

BTX is trading at $8.85, which is 94% of its 52-week high ($9.44) and 82% above its 52-week low ($6.13).

How volatile is BTX?

BTX has a Beta of 1.52 and 52-week volatility of 27%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.